Positive Allosteric Modulation of the Muscarinic M1Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior-Reference-Cited by-同舟云学术

Positive Allosteric Modulation of the Muscarinic M1Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior

Published:2016-09-14 Issue:2 Volume:359 Page:354-365
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Choy Kwok H. C.^ORCID,Shackleford David M.,Malone Daniel T.,Mistry Shailesh N.,Patil Rahul T.,Scammells Peter J.,Langmead Christopher J.,Pantelis Christos,Sexton Patrick M.,Lane Johnathan R.,Christopoulos Arthur

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference131 articles.

1. Mechanistic Insights into Allosteric Structure-Function Relationships at the M1 Muscarinic Acetylcholine Receptor

2. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

3. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response;Bakshi;J Pharmacol Exp Ther,1994

4. The M1/M4 preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia

5. Relational Memory in First Episode Psychosis: Implications for Progressive Hippocampal Dysfunction After Illness Onset

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment;Clinical Drug Investigation;2024-06-21

2. Design, synthesis and evaluation of novel 2-phenyl-3-(1H-pyrazol-4-yl)pyridine positive allosteric modulators for the M4 mAChR;European Journal of Medicinal Chemistry;2023-10

3. Markers of muscarinic deficit for individualized treatment in schizophrenia;Frontiers in Psychiatry;2023-01-09

4. Opportunities and challenges for the development of M ₁ muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits;British Journal of Pharmacology;2022-12-04

5. Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia;American Journal of Psychiatry;2022-09-01